| Ceftazidime |
| Biological
agents targetted |
Glanders |
| Generally
effective against |
Effective
against a broad range of Gram-positive and Gram-negative bacteria.
It is effective against bacteria resistant to ampicillin and other
cephalosporins. |
| Available
forms |
Usually
supplied as a dry powder (Ceptaz or Fortaz) for injection or infusion. |
| Indications
and usage |
Ceftazidime
may be indicated in an extremely wide variety of Gram-positive and
Gram-negative infections of the respiratory tract, the skin, urinary
and genital tracts, septicemia, the abdominal cavity, and the central
nervous system. Sensitivity of the pathogen must be demonstrated first. |
| Contraindications |
Any
known adverse response to ceftazidime, other cephalosporins or beta
lactam antibiotics such as
ampicillin; a history of colitis or renalor hepatic insufficiency. |
| Drug
interactions |
When
used for prolonged treatments in combination with high levels of
aminoglycoside antibiotics or potent diuretics, kidney damage has
been observed. |
| Adverse
reactions and side effects
NOTE:
all such reactions are rare. |
Pseudomembranous
colitis, an unpleasant diarrhea-like disease resulting from the
digestive tract being colonized by Clostridium difficile
after the antibiotic has killed other bacterial in the tract is
seen with ceftazidime. Other adverse reactions include:
- urticaria;
- kidney damage;
- loss of liver function;
|
| Mode
of action |
Ceftazidime
inhibits one the enzymes involved in the synthesis of the bacterial
cell walls. The loss of the stability conferred by the wall leads
to the cell lysing. |
| Structure |
 |
| Chemical
names |
1-[[(6R,7R)-7-[2-(2-amino-4-thiazolyl)glyoxylamido]-2-carboxy-8-oxo-5-thia-1-azabicyclo-[4.2.0]oct2-en-3-yl]methyl]pyridinium
hydroxide inner salt |
| CAS
Registry number |
72558-82-8 |
|
Synonyms
and trade names
(known and reported, not all may be current.)
|
| Trade
Name |
Country |
| Alfacef |
South
Korea |
| Ceffotan |
Colombia |
| Cefortam |
Portugal |
| Cefpiran |
Peru |
| Ceftazim |
Mexico |
| Ceftidin |
India |
| Ceftim |
Italy,
Portugal |
| Ceftum |
Indonesia |
| Ceptaz |
United
States |
| Cetazum |
Indonesia |
| Fortam |
|
| Fortax |
|
| Fortaz |
|
| Fortum |
Australia;
Austria; Bahamas; Bahrain; Barbados; Belize; Benin; Bermuda; Bulgaria;
Burkina Faso; Colombia; Costa Rica; Curacao; Cyprus; Czech Republic;
Denmark; Dominican Republic; Ecuador; Egypt; El Salvador; Ethiopia;
France; Gambia; Germany; Ghana; Guinea; Guyana; Honduras; Hong Kong;
Hungary; India; Indonesia; Iran; Iraq; Ireland; Israel; Ivory Coast;
Jamaica; Jordan; Kenya; Korea; Kuwait; Lebanon; Liberia; Libya;
Malawi; Malaysia; Mali; Mauritania; Mauritius; Mexico; Morocco;
Netherlands; Netherlands Antilles; New Zealand; Niger; Nigeria;
Norway; Oman; Panama; Peru; Philippines; Qatar; Republic of South
Africa; Republic of Yemen; Saudia Arabia; Senegal; Seychelles; Sierra
Leone; Sudan; Surinam; Sweden; Syria; Taiwan; Tanzania; Thailand;
Trinidad; Tunisia; Uganda; United Arab Emirates; United Kingdom;
Zambia; Zimbabwe |
| Fortum
Pro |
Hungary |
| Fortumset |
France |
| Forzid |
Indonesia,
Thailand |
| Ftazidime |
Greece |
| Glazidim |
Belgium,
Finland, Italy |
| Izadima |
Colombia,
Mexico |
| Kefadim |
Belgium; Benin; Burkina Faso; Colombia; Czech Republic; Ethiopia;
Gambia; Ghana; Guinea; Ivory Coast; Kenya; Liberia; Malawi; Mali;
Mauritania; Mauritius; Morocco; Niger; Nigeria; Senegal; Seychelles;
Sierra Leone; Sudan; Taiwan; Tanzania; Tunisia; Uganda; Zambia; Zimbabwe |
| Kefamin |
|
| Kefazim |
Austria |
| Kefzim |
Republic
of South Africa |
| Magnacef |
|
| Mirocef |
|
| Modacin |
Japan |
| Panzid |
Italy |
| Pentacef |
United
States |
| Potendal |
|
| Solvetan |
Greece |
| Spectrum |
Italy |
| Starcef |
Italy |
| Tagal |
Mexico |
| Tazicef |
|
| Tazidime |
Canada |
| Tazime |
South
Korea |
| Thidim |
Indonesia |
| Tortam |
|
| Waytrax |
Mexico |
| Zadolina |
Mexico |
| Zibac |
Indonesia |
| Zytaz |
India |